What does CUSIP G3141W122 represent in this 13F holders report?

CUSIP G3141W122 is the security identifier for EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 used to aggregate holder disclosures.

How many institutions held EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in Q2 2023?

No institutional holders were reported for EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in Q2 2023; review adjacent reporting periods for trend context.

202 (EUCRW)

CUSIP: G3141W122

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / *W EXP 10/23/202
Total 13F shares: 0
Share change: -1,364,106
Total reported value: $0
Number of holders: 0
Value change: -$52,333
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP G3141W122?
CUSIP G3141W122 identifies EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2023

Recent filing periods for CUSIP G3141W122:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW)

Q2 2023 13F Holders as of 30 Jun 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 as of Q2 2023.